Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€29.40
Target price
07.02.25
€46.44
Performance (%)
-20.20%
Price
08.05.24
€23.46
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.20%. This prediction currently runs until 07.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | 10.608% | 10.608% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $50.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.94
16.01.24
16.01.24
€45.92
16.01.25
16.01.25
-26.55%
08.05.24
08.05.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.00
30.11.23
30.11.23
€45.85
30.11.24
30.11.24
6.64%
08.05.24
08.05.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.74
08.08.24
08.08.24
-6.42%
08.05.24
08.05.24